BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8757635)

  • 1. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation.
    Goletti D; Weissman D; Jackson RW; Graham NM; Vlahov D; Klein RS; Munsiff SS; Ortona L; Cauda R; Fauci AS
    J Immunol; 1996 Aug; 157(3):1271-8. PubMed ID: 8757635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.
    De Haas CJ; de Vos NM; Visser MR; Snippe H; Verhoef J
    Clin Exp Immunol; 1998 Feb; 111(2):286-92. PubMed ID: 9486394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes.
    Toossi Z; Xia L; Wu M; Salvekar A
    Clin Exp Immunol; 1999 Aug; 117(2):324-30. PubMed ID: 10444265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Humanized Mouse Model for HIV and Tuberculosis Co-infection Studies.
    Bohórquez JA; Adduri S; Ansari D; John S; Florence J; Adejare O; Singh G; Konduru N; Jagannath C; Yi G
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of Human Immunodeficiency Virus-
    Wong K; Nguyen J; Blair L; Banjanin M; Grewal B; Bowman S; Boyd H; Gerstner G; Cho HJ; Panfilov D; Tam CK; Aguilar D; Venketaraman V
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33172001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung.
    Nakata K; Rom WN; Honda Y; Condos R; Kanegasaki S; Cao Y; Weiden M
    Am J Respir Crit Care Med; 1997 Mar; 155(3):996-1003. PubMed ID: 9117038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology.
    Thompson LJ; Genovese J; Hong Z; Singh MV; Singh VB
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial immune response after exposure to
    Aiello A; Najafi-Fard S; Goletti D
    Front Immunol; 2023; 14():1244556. PubMed ID: 37662901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis.
    Grifoni A; Alonzi T; Alter G; Noonan DM; Landay AL; Albini A; Goletti D
    Front Immunol; 2023; 14():1146704. PubMed ID: 37292210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland.
    Zeeb M; Tepekule B; Kusejko K; Reiber C; Kälin M; Bartl L; Notter J; Furrer H; Hoffmann M; Hirsch HH; Calmy A; Cavassini M; Labhardt ND; Bernasconi E; Braun DL; Günthard HF; Kouyos RD; Nemeth J;
    Clin Infect Dis; 2023 Nov; 77(9):1303-1311. PubMed ID: 37257071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic".
    Azevedo-Pereira JM; Pires D; Calado M; Mandal M; Santos-Costa Q; Anes E
    Microorganisms; 2023 Mar; 11(4):. PubMed ID: 37110276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes.
    Goletti D; Pisapia R; Fusco FM; Aiello A; Van Crevel R
    Int J Tuberc Lung Dis; 2023 Apr; 27(4):284-290. PubMed ID: 37035976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for Implementation: Management of TB in HIV and Pregnancy.
    Jones AJ; Mathad JS; Dooley KE; Eke AC
    Curr HIV/AIDS Rep; 2022 Dec; 19(6):455-470. PubMed ID: 36308580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose Rifampicin Mediated Systemic Alterations of Cytokines, Chemokines, Growth Factors, Microbial Translocation Markers, and Acute-Phase Proteins in Pulmonary Tuberculosis.
    Kathamuthu GR; Bhavani PK; Singh M; Saini JK; Aggarwal A; Ansari MSS; Garg R; Babu S
    Front Pharmacol; 2022; 13():896551. PubMed ID: 35910352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis.
    Kumar NP; Moideen K; Viswanathan V; Sivakumar S; Ahamed SF; Ponnuraja C; Hissar S; Kornfeld H; Babu S
    Clin Infect Dis; 2022 Nov; 75(10):1820-1826. PubMed ID: 35352112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV-
    Tisthammer KH; Kline C; Rutledge T; Diedrich CR; Ita S; Lin PL; Ambrose Z; Pennings PS
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.
    Amin O; Powers J; Bricker KM; Chahroudi A
    Front Immunol; 2021; 12():757400. PubMed ID: 34745130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoir.
    Xun J; Qi T; Zou L; Tang Q; Shen Y; Yang J; Xie L; Ji Y; Zhang R; Liu L; Wang J; Steinhart C; Wang Z; Tang Y; Song W; Sun J; Cheng J; Le X; Wu H; He X; Chen R; Chen J; Lu H
    AIDS Res Ther; 2020 Oct; 17(1):63. PubMed ID: 33076959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption.
    Wu Y; Pinkevych M; Xu Z; Keele BF; Davenport MP; Cromer D
    Proc Biol Sci; 2020 Aug; 287(1933):20200354. PubMed ID: 32811309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Human Immunodeficiency Virus-1 Replication in CD4+ T Cells Derived From Individuals With Latent Mycobacterium tuberculosis Infection.
    He X; Eddy JJ; Jacobson KR; Henderson AJ; Agosto LM
    J Infect Dis; 2020 Oct; 222(9):1550-1560. PubMed ID: 32417884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.